GREAT CHEMISTRY CURES
Live / Registered — Registered (as of 01 Apr 2025)
What this means for you
Registered since 01 Apr 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 01 Apr 2031: the §8 declaration of use).
Record
- Serial number
- 97277880
- Registration number
- 7747025
- Mark type
- Word mark
- Filed
- 22 Feb 2022
- Published for opposition
- 27 Dec 2022
- Registered
- 01 Apr 2025
- Next maintenance filing
- §8 declaration of use, due by 01 Apr 2031 (grace period to 01 Oct 2031)
- Attorney of record
- Joshua S. Jarvis, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of viral infections and hepatic diseases and disorders
- Class 042 — Scientific and technological services: Research and development services in the field of identification of compounds as potential therapeutic products
Owner
- Enanta Pharmaceuticals, Inc., Watertown, MA, US
- Enanta Pharmaceuticals, Inc., Watertown, MA, US
- Enanta Pharmaceuticals, Inc., Watertown, MA, US
Prosecution history
- 01 Apr 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 01 Apr 2025 — REGISTERED-PRINCIPAL REGISTER
- 10 Mar 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Mar 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Mar 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Dec 2024 — USE AMENDMENT FILED
- 02 Mar 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Dec 2024 — TEAS STATEMENT OF USE RECEIVED
- 06 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Aug 2024 — SOU EXTENSION 3 GRANTED
- 06 Aug 2024 — SOU EXTENSION 3 FILED
- 06 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 14 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Feb 2024 — SOU EXTENSION 2 GRANTED
- 13 Feb 2024 — SOU EXTENSION 2 FILED